
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp is benefiting from favorable revenue growth in its Personal Care segment, which has exhibited a remarkable +12.3% year-over-year growth in 2023, followed by +7.7% in 2024 and +7.4% year-to-date growth in 2025. The recently finalized +2.6% Medicare Hospice rate increase for FY2026 is expected to further enhance revenue potential for the Hospice segment, alongside anticipated local-level operational improvements driven by leadership changes. Additionally, M&A activity is projected to provide near-term upside, particularly as the Hospice segment stabilizes with consistent growth rates of +5% to +7%.
Bears say
Addus HomeCare has experienced same-store declines due to ongoing Medicaid redeterminations, leading to administrative bottlenecks that hinder patient onboarding and result in higher discharge rates compared to admissions. Approximately 97% of the company's segment revenues as of 2025 year-to-date are affected by uncertainties in the Medicaid funding environment, exacerbated by legislative changes such as the One Big Beautiful Bill Act (OBBBA). Despite strong operational execution and a favorable long-term demand outlook, the equity valuation remains disconnected from the overall earnings trajectory, indicating potential financial instability.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares